Price Transparency: Posting Numbers Is Only the Starting Point
- Private practices outperform: 86% of independent urology clinics quote cash prices versus 70% of hospital-based and 62% of academic clinics.
-...

Created by GrowthMasters Team
Practical playbooks, case studies, and investor insights for multi-site health CEOs
Explore the latest content tracked by AJ || CEO Advice Multi-Site Health Playbook
Minority, non-controlling capital now funds ring-fenced businesses without shifting day-to-day control, as Apollo’s €3bn Bayer structure demonstrates....
Hospitals risk clinical, legal, and financial harm when AI enters without board oversight. Strategy must start with governance, priorities,...
Recent New Jersey cases underscore the need for rigorous compliance in referral and documentation practices.
Hospital leaders must embed merger approval, legislative oversight, community value, and transaction transparency into deal strategy from day one—not...
Health systems can treat service lines as strategic engines for integration, standardization, and scalable growth.
Auxpanel shows how targeted dashboards help CEOs track location-level performance and automate reporting across expanding platforms.
Multi-site EHS software succeeds when operators standardize core processes while allowing local flexibility for regulations and risks.
Non-listed BDC redemptions hit a record 12.4% of NAV in Q2 2026, with sponsors meeting just 38% of $15.4 billion in requests and net outflows reaching...
Family offices are actively cutting private equity allocations after a three-year liquidity crunch left distributions at just 11.2% of NAV in 2023.
-...
PE sponsors in 2026 face LP pressure to deploy record dry powder, targeting founder-led firms with premium multiples.
The goal is to become stronger, not simply larger. Start by confirming the existing practice shows stable revenue, consistent cash flow, and...
Multi-site healthcare groups lose margin to fragmented indirect spend across locations, vendors, and purchasing habits.
Medicare's new NTAP pays up to $137.53 per eligible inpatient CT case using Aidoc’s specific FDA-cleared tool starting Oct. 1.
Aging buyout holdings are moving strain from limited partners to the banking system.
Specialist firms like HealthEdge target founder-led healthcare companies needing more than capital.